In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

By his estimate, that means AI has been around at Sanofi for about a third of the "discovery" process for some drugs. That ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

FDA approval requires the manufacturer to be able to prove ... meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate prescription.

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

Sanofi’s lofty position in diabetes has been undermined in the last few years by the loss of patent protection for its biggest-selling product Lantus (insulin glargine) and disappointing take-up ...